Euromed SA Continues Its Expansion By Acquiring Probelte Biotechnology
BRIDGEVILLE, Penn. (PRWEB) November 08, 2017 -- In keeping with the company’s recent pattern of growth – in creating new, innovative ingredients, additional personnel, and soon an expanded top of the line facility -- Euromed is proud to announce the acquisition of Probelte Biotechnology, a premium manufacturer of nutraceutical ingredients. ProbelteBio, located in Murcia, Spain, has a focus on ingredients that are based on the healthy “Mediterreanean Diet.” ProbelteBio was founded in 2011 and specializes in environmentally friendly extraction technology. Their location in the agriculturally-rich region, known as the “Garden of Europe” in Murcia, provides ready access to plant origin raw materials, and traceability for their products such as olive and pomegranate.
ProbelteBio prides itself on producing botanical extracts with proven efficacy, and as a result, has generated an impressive portfolio of scientific studies. Their extraction technology -- and published efficacy studies -- have been protected as Intellectual Property in the form of several patents, as well as numerous product trademarks, all of which have been received by the company.
The firm invested 22 million Euros in 2011 in advanced nutraceutical processing and, as a result, has obtained no less than six (6) industrial certifications. These include FSSC 22000, UNE-EN ISO 22000, and ISO TS 22002-1, along with manufacturing oversight under HACCP compliance in its spacious and modern 215,000-square foot facility.
“The future for our rapidly advancing, technology-driven society is for consumers to obtain nutritionally enhanced foods and health-promoting dietary supplements,” according to Guy Woodman, General Manager of Euromed USA, Inc. “ProbelteBio helps us satisfy this societal need by complementing Euromed’s philosophy of sustainability and traceability to the control of their locally-sourced agricultural raw materials and concentrated extracts."
The significant addition of ProbelteBio accelerates Euromed’s product portfolio expansion, capabilities, and innovation objectives, particularly into vegetable and fruit-based nutraceutical ingredients. The corporate research and development department will continue to be based at its Barcelona headquarters where its expanded laboratory and innovation center will be completed in December 2017.
ABOUT EUROMED
Euromed supplies standardized botanical and herbal extracts and natural active substances for use in the pharmaceutical, health food, and cosmetics industries. By extracting the key phytonutrients, the company can guarantee its products meet the precise chemical specifications. Euromed was founded 46 years ago by Madaus AG., and in 2016 the company was acquired by The Riverside Company; the US facility is in Bridgeville, Pennsylvania. For more information, visit http://www.euromedusa.com or email [email protected] or call 412-279-8808.
Linda Bryer, Matisse & Merlot, http://www.EuromedUSA.com, +1 8315888767, [email protected]
Share this article